Monitoring BCG immunotherapy for high risk urothelial cancer of the urinary bladder - a novel biomarker

被引：0
|
作者：
Ardelt, P. U. [1 ]
Kneitz, B. [1 ]
Adam, P. [2 ]
Reiss, C. [3 ]
Kocot, A. [1 ]
Fensterle, J. [4 ]
Pasqualini, R. [5 ]
Arap, W. [5 ]
Gerharz, E. W. [1 ]
Riedmiller, H. [1 ]
机构：
[1] Bavarian Julius Maximilians Univ, Dept Urol & Pediat Urol, Sch Med, Wurzburg, Germany
[2] Bavarian Julius Maximilians Univ, Inst Pathol, Sch Med, Wurzburg, Germany
[3] Avarian Julius Maximilians Univ, Sch Med, Wurzburg, Germany
[4] Bavarian Julius Maximilians Univ, Sch Med, Inst Med Radiol & Cell Res, Wurzburg, Germany
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(09)72140-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
    R F M Bevers
    K-H Kurth
    D H J Schamhart
    British Journal of Cancer, 2004, 91 : 607 - 612
  • [2] Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
    Bevers, RFM
    Kurth, KH
    Schamhart, DHJ
    BRITISH JOURNAL OF CANCER, 2004, 91 (04) : 607 - 612
  • [3] URINARY MET LEVEL AS A NOVEL BIOMARKER FOR UROTHELIAL CARCINOMA OF THE BLADDER
    Sorbellini, Maximiliano
    McNeil, Brian
    Giubellino, Alessio
    Dharmawardana, Gagani
    Simpson, Haley
    Coleman, Jonathan
    Getzenberg, Robert
    Netto, George
    Pinto, Peter
    Linehan, Marston
    Bottaro, Donald
    JOURNAL OF UROLOGY, 2012, 187 (04): : E520 - E520
  • [4] Urinary Met Level as a Novel Biomarker for Urothelial Carcinoma of the Bladder
    Sorbellini, M.
    McNeal, B.
    Athauda, G.
    Cohen, B.
    Giubellino, A.
    Simpson, H.
    Coleman, J.
    Getzenberg, R. H.
    Netto, G. J.
    Linehan, M. W.
    Pinto, P. A.
    Bottaro, D. P.
    LABORATORY INVESTIGATION, 2011, 91 : 225A - 225A
  • [5] Urinary Met Level as a Novel Biomarker for Urothelial Carcinoma of the Bladder
    Sorbellini, M.
    McNeal, B.
    Athauda, G.
    Cohen, B.
    Giubellino, A.
    Simpson, H.
    Coleman, J.
    Getzenberg, R. H.
    Netto, G. J.
    Linehan, M. W.
    Pinto, P. A.
    Bottaro, D. P.
    MODERN PATHOLOGY, 2011, 24 : 225A - 225A
  • [6] Urinary Met level as a novel biomarker for urothelial carcinoma of the bladder
    Sorbellini, M.
    McNeil, B.
    Cohen, B.
    Athauda, G.
    Giubellino, A.
    Coleman, J.
    Netto, G. J.
    Getzenberg, R. H.
    Linehan, W.
    Bottaro, D. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Cytokine gene polymorphisms are associated with risk of urinary bladder cancer and recurrence after BCG immunotherapy
    Ahirwar, Dinesh K.
    Agrahari, Anita
    Mandhani, Anil
    Mittal, Rama D.
    BIOMARKERS, 2009, 14 (04) : 213 - 218
  • [8] BCG in Bladder Cancer Immunotherapy
    Jiang, Song
    Redelman-Sidi, Gil
    CANCERS, 2022, 14 (13)
  • [9] Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer
    Zhang, Yu-Rui
    Shi, Lei
    Wu, Hui
    Tang, Dong-Dong
    Wang, Shao-Min
    Liu, Hong-Min
    Zhang, Li-Rong
    Song, Dong-Kui
    TUMORI JOURNAL, 2014, 100 (06): : 660 - 666
  • [10] The novel immunotherapy for BCG-resistant bladder cancer by ImmuneNanoVaccine
    Huang, P.
    Lin, W.
    Zhou, T.
    Igawa, K.
    Kasai, T.
    Sadahira, T.
    Michiue, H.
    Araki, M.
    EUROPEAN UROLOGY, 2024, 85 : S1502 - S1502
12345